Alnylam (ALNY) Reports 238% Growth in Amvuttra Since February Launch, RBC Raises Price Target
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) ranks among the best biotech stocks to buy. RBC Capital maintained its Outperform rating for Alnylam Pharmaceuticals, Inc.